The U.S. needs to support American-made medicines
CPA’s Take: CivicaRX CEO Martin VanTrieste explains why it is essential, and achievable to reshore pharmaceutical production to the US. Two years ago, a group
Kodak to Produce Drug Ingredients in U.S. Thanks to Defense Production Act
CPA’s take: It’s great to see the Trump administration invoking the DPA to lend Kodak some serious money, great to see a historic US company getting
Industry Group Coalition Supports Reshoring PPE Manufacturing
The AFL-CIO, USW, and 19 other groups released a joint statement on bringing PPE manufacturing back to the States. On July 20, a coalition of
The Fight To Reshore US Pharmaceuticals
Editor’s Note: Michael Stumo is CEO of the Coalition for a Prosperous America. Follow him at @michael_stumo The coronavirus pandemic has revealed a troubling truth: Global
“We Need More Equipment & We Need It Now” Reshoring Medical Supplies Could Create 302,000 New US Jobs
By Steven L. Byers, PhD and Jeff Ferry The US is in the midst of a public health crisis and the country is struggling with
Reshoring US Pharmaceutical Production Would Create 800K Jobs
Health, Security, Economic Benefits from Reshoring By Steven L. Byers, PhD and Jeff Ferry With the spreading coronavirus pandemic, Americans are becoming increasingly aware of
China RX Exposes Risks of Dependence on China for Medicines
Excerpt: How did the pharmaceutical industry start sourcing pharmaceuticals in China? After her presentation at the Made in America trade show last month, I met Rosemary